Skip to main content
. 2024 Dec 21;21:220. doi: 10.1186/s12984-024-01527-2

Table 2.

Primary (Motor Activity Log-14 Item Version amount of Use Subscale (MAL-14 AOU)) and secondary outcomes (MAL-14 Quality of Movement subscale (MAL-14 QOM)), Fugl-Meyer Assessment- Upper Extremity subscale (FMA-UE), Action Research Arm Test (ARAT), modified Rankin Scale (mRS) and EuroQol five dimensions five levels questionnaire (EQ-5D-5 L) index value and visual analogue scale (VAS) score and global rating of Perceived Changes (GRPC)) at baseline, after the 6-week intervention and after the 6-week follow-up for the total enrolled study population (n = 42) (mean ± standard deviation). * significant difference between timepoints (baseline, post-intervention, follow-up) (p < 0.05)

Baseline Post-Intervention Follow-up
Intervention Control Intervention Control Intervention Control
MAL-14
AOU * 2.0 (± 1.1) 1.9 (± 1.2) 2.1 (± 1.2) 2.0 (± 1.2) 2.3 (± 1.1) 2.0 (± 1.2)
QOM * 1.7 (± 0.9) 1.6 (± 1.2) 1.9 (± 1.0) 1.8 (± 1.2) 2.0 (± 1.0) 1.8 (± 1.2)
FMA-UE *

35.6

(± 14.8)

34.7 (± 14.9)

37.2

(± 16.2)

35.8 (± 15.4)

37.3

(± 15.4)

35.6 (± 14.9)
ARAT *

31.0

(± 18.1)

29.5

(± 18.8)

32.5

(± 19.3)

31.6

(± 18.8)

33.7

(± 19.4)

32.0 (± 18.6)
mRS 2.5 (± 0.5) 2.7 (± 0.8) 2.5 (± 0.5) 2.7 (± 0.8) 2.5 (± 0.5) 2.7 (± 0.8)
EQ-5D-5 L
Index value 0.8 (± 0.1) 0.8 (± 0.2) 0.8 (± 0.1) 0.8 (± 0.2) 0.8 (± 0.1) 0.8 (± 0.2)
VAS

66.5

(± 15.0)

65.0 (± 7.0)

65.6

(± 16.3)

69.4

(± 16.7)

67.8

(± 16.2)

64.7

(± 20.5)

GRPC
Affected arm use 4.7 (± 1.1) 5.1 (± 1.2) 4.7 (± 1.0) 4.7 (± 1.3)
Physical activity 4.9 (± 0.8) 5.1 (± 0.9) 4.9 (± 1.0) 4.8 (± 1.2)